BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2645 related articles for article (PubMed ID: 21330961)

  • 1. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
    De Vecchis R; Ciccarelli A; Pucciarelli A
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure.
    Cioffi G; Tarantini L; Pulignano G; Del Sindaco D; De Feo S; Opasich C; Dilenarda A; Stefenelli C; Furlanello F
    J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):419-27. PubMed ID: 17502758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.
    De Vecchis R; Ariano C; Esposito C; Giasi A; Cioppa C; Cantatrione S
    Minerva Cardioangiol; 2012 Oct; 60(5):517-29. PubMed ID: 23018431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
    Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
    Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.
    Sun WY; Reiser IW; Chou SY
    Am J Kidney Dis; 2006 May; 47(5):798-808. PubMed ID: 16632018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.
    Ricci F; Ramírez T; Marmorato R; Vega J; Pagán P; López JE; Soto-Salgado M; Cangiano JL
    P R Health Sci J; 2013 Jun; 32(2):63-7. PubMed ID: 23781621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound evaluation of the inferior vena cava collapsibility index in congestive heart failure patients treated with intravenous diuretics: new insights about its relationship with renal function: an observational study.
    De Vecchis R; Ariano C; Fusco A; Ciccarelli A; Cioppa C; Giasi A; Esposito C; Cantatrione S
    Anadolu Kardiyol Derg; 2012 Aug; 12(5):391-400. PubMed ID: 22564268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
    De Vecchis R; Di Biase G; Ariano C; Cioppa C; Giasi A; Ciccarelli A; Pucciarelli A; Cantatrione S
    Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic strategies in patients with acute decompensated heart failure.
    Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
    N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
    Dini FL; Ghio S; Klersy C; Rossi A; Simioniuc A; Scelsi L; Genta FT; Cicoira M; Tavazzi L; Temporelli PL
    Int J Clin Pract; 2013 Jul; 67(7):656-64. PubMed ID: 23758444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous infusion versus bolus injection of loop diuretics in acute heart failure: a literature review].
    Leto L; Aspromonte N; Feola M
    G Ital Cardiol (Rome); 2012 Apr; 13(4):263-72. PubMed ID: 22495643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 133.